Neurogene (NGNE) Assets Average (2018 - 2025)
Historic Assets Average for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $292.6 million.
- Neurogene's Assets Average rose 7012.94% to $292.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $292.6 million, marking a year-over-year increase of 7012.94%. This contributed to the annual value of $279.2 million for FY2024, which is N/A changed from last year.
- Per Neurogene's latest filing, its Assets Average stood at $292.6 million for Q3 2025, which was up 7012.94% from $306.3 million recorded in Q2 2025.
- Neurogene's 5-year Assets Average high stood at $325.5 million for Q1 2025, and its period low was $91.8 million during Q3 2023.
- Over the past 3 years, Neurogene's median Assets Average value was $187.6 million (recorded in 2024), while the average stood at $204.3 million.
- Examining YoY changes over the last 5 years, Neurogene's Assets Average showed a top increase of 9493.05% in 2024 and a maximum decrease of 3053.97% in 2024.
- Quarter analysis of 3 years shows Neurogene's Assets Average stood at $156.1 million in 2023, then soared by 60.13% to $249.9 million in 2024, then grew by 17.06% to $292.6 million in 2025.
- Its last three reported values are $292.6 million in Q3 2025, $306.3 million for Q2 2025, and $325.5 million during Q1 2025.